Pain assessment in elderly adults with dementia

Grants

Funding Acknowledgements

TH declares that, although he does not have a financial interest in the PACSLAC/PACSLAC-II, he is one of the developers of the PACSLAC/PACSLAC-II, an instrument that is being considered, along with others, in this Review. SJG receives payments from CSL Pty and Pfizer for participation on advisory boards. SJG declares no competing interests related to the content of the proposed Review. AL receives support from Mundipharma GmbH (partly beside the Robert Bosch Foundation) a present research project, validation of the German PAINAD, a double-blind randomised trial aimed to investigate the validity of the PAINAD scale in people with severe dementia, unable to give oral response; additionally, AL has received renumeration in the course of giving individual lectures at Mundipharma GmbH and Pfizer GmbH during the past 5 years. JHS, KH, KMP, and KDC declare no competing interests.